Clinic of Cranio-Maxillofacial and Oral Surgery, Center of Dental Medicine, University of Zurich, 8032 Zurich, Switzerland.
Statistical Services, Center of Dental Medicine, University of Zurich, 8032 Zurich, Switzerland.
Sensors (Basel). 2021 Nov 7;21(21):7402. doi: 10.3390/s21217402.
This study aimed to analyze the diagnostic reliability of radiographic assessment of cystic lesions using a pre-set, manufacturer-specific, low-dose mode compared to a standard-dose dental cone-beam computed tomography (CBCT) imaging protocol.
Forty pig mandible models were prepared with cystic lesions and underwent both CBCT protocols on an Orthophos SL Unit (Dentsply-Sirona, Bensheim, Germany). Qualitative and quantitative analysis of CBCT data was performed by twelve investigators independently in SIDEXIS 4 (Dentsply-Sirona) using a trial-specific digital examination software tool. Thereby, the effect of the two dose types on overall detectability rate, the visibility on a scale of 1 (very low) to 10 (very high) and the difference between measured radiographic and actual lesion size was assessed.
Low-dose CBCT imaging showed no significant differences considering detectability (78.8% vs. 81.6%) and visibility (9.16 vs. 9.19) of cystic lesions compared to the standard protocol. Both imaging protocols performed very similarly in lesion size assessment, with an apparent underestimation of the actual size.
Low-dose protocols providing confidential diagnostic evaluation with an improved benefit-risk ratio according to the ALADA principle could become a promising alternative as a primary diagnostic tool as well as for radiological follow-up in the treatment of cystic lesions.
本研究旨在分析使用预设的、制造商特定的低剂量模式与标准剂量口腔锥形束计算机断层扫描 (CBCT) 成像方案相比,对囊性病变的放射学评估的诊断可靠性。
四十个猪下颌骨模型制备有囊性病变,并在 Orthophos SL 单元(登士柏西诺德,本斯海姆,德国)上进行两种 CBCT 方案。十二名研究人员独立使用特定于试验的数字检查软件工具在 SIDEXIS 4(登士柏西诺德)中对 CBCT 数据进行定性和定量分析。从而评估两种剂量类型对总体检出率、1(非常低)到 10(非常高)的可见度以及测量的放射学和实际病变大小之间的差异的影响。
与标准方案相比,低剂量 CBCT 成像在囊性病变的检出率(78.8% 对 81.6%)和可见度(9.16 对 9.19)方面没有显示出显著差异。两种成像方案在病变大小评估方面表现非常相似,存在实际尺寸的明显低估。
根据 ALADA 原则提供保密诊断评估并改善获益风险比的低剂量方案可能成为治疗囊性病变的主要诊断工具以及放射学随访的有前途的替代方案。